
Mati Therapeutics
Developer of a novel, non-invasive sustained drug delivery platform designed to deliver medication to the surface of the eye for improved treatment of ocular conditions. The company's platform offers ...
Valuation
$0
Share Price
N/A
Total Raised
$13.7M
Last Round
N/A